Bayer Shares Fall on Renewed Uncertainty Over $7 Billion U.S. Settlement

Dow Jones06-02

By Adria Calatayud

Bayer shares fell after plaintiffs sought to transfer a proposed $7.25 billion U.S. settlement over Roundup weedkiller to a federal court in California, stoking renewed uncertainty around the company's attempt to contain litigation risk this year.

Shares in the German agricultural-and-pharmaceutical group were down 5% in European midday trading, taking their year-to-date loss to nearly 10%.

Bayer said it plans to oppose a conditional order from the Judicial Panel on Multidistrict Litigation regarding the proper venue for the settlement. The company in February proposed the settlement to resolve current and future claims alleging its Roundup product causes cancer, with payments made over two decades but front-loaded to this year.

"We are confident in our arguments that the class settlement case should be remanded to Missouri State Court," a Bayer spokesman said.

The move comes two days before a deadline for plaintiffs to opt out of the settlement, which the company considers still valid.

The decision might raise questions among investors about whether the settlement still holds given the potential involvement of a California federal judge who was cautious on this class action in a recent hearing, analysts at Bank of America wrote in a note to clients.

Write to Adria Calatayud at adria.calatayud@wsj.com

(END) Dow Jones Newswires

June 02, 2026 07:06 ET (11:06 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2640917344?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-02 19:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2640917344","market":"sg","top_or_hot":-1,"title":"Bayer Shares Fall on Renewed Uncertainty Over $7 Billion U.S. Settlement","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adria Calatayud \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Bayer shares fell after plaintiffs sought to transfer a proposed $7.25 billion U.S. settlement over Roundup weedkiller to a federal court in California, stoking renewed uncertainty around the company's attempt to contain litigation risk this year. \n</p>\n<p>\n  Shares in the German agricultural-and-pharmaceutical group were down 5% in European midday trading, taking their year-to-date loss to nearly 10%. \n</p>\n<p>\n  Bayer said it plans to oppose a conditional order from the Judicial Panel on Multidistrict Litigation regarding the proper venue for the settlement. The company in February proposed the settlement to resolve current and future claims alleging its Roundup product causes cancer, with payments made over two decades but front-loaded to this year. \n</p>\n<p>\n  \"We are confident in our arguments that the class settlement case should be remanded to Missouri State Court,\" a Bayer spokesman said. \n</p>\n<p>\n  The move comes two days before a deadline for plaintiffs to opt out of the settlement, which the company considers still valid. \n</p>\n<p>\n  The decision might raise questions among investors about whether the settlement still holds given the potential involvement of a California federal judge who was cautious on this class action in a recent hearing, analysts at Bank of America wrote in a note to clients. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adria Calatayud at adria.calatayud@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 02, 2026 07:06 ET (11:06 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bayer Shares Fall on Renewed Uncertainty Over $7 Billion U.S. Settlement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBayer Shares Fall on Renewed Uncertainty Over $7 Billion U.S. Settlement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-06-02 19:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adria Calatayud \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Bayer shares fell after plaintiffs sought to transfer a proposed $7.25 billion U.S. settlement over Roundup weedkiller to a federal court in California, stoking renewed uncertainty around the company's attempt to contain litigation risk this year. \n</p>\n<p>\n  Shares in the German agricultural-and-pharmaceutical group were down 5% in European midday trading, taking their year-to-date loss to nearly 10%. \n</p>\n<p>\n  Bayer said it plans to oppose a conditional order from the Judicial Panel on Multidistrict Litigation regarding the proper venue for the settlement. The company in February proposed the settlement to resolve current and future claims alleging its Roundup product causes cancer, with payments made over two decades but front-loaded to this year. \n</p>\n<p>\n  \"We are confident in our arguments that the class settlement case should be remanded to Missouri State Court,\" a Bayer spokesman said. \n</p>\n<p>\n  The move comes two days before a deadline for plaintiffs to opt out of the settlement, which the company considers still valid. \n</p>\n<p>\n  The decision might raise questions among investors about whether the settlement still holds given the potential involvement of a California federal judge who was cautious on this class action in a recent hearing, analysts at Bank of America wrote in a note to clients. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adria Calatayud at adria.calatayud@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 02, 2026 07:06 ET (11:06 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BAYRY","symbol_name":"Bayer A.G.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2640917344","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2640917344","pubTimestamp":1780398360,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Bayer shares fell after plaintiffs sought to transfer a proposed $7.25 billion U.S. settlement over Roundup weedkiller to a federal court in California, stoking renewed uncertainty around the company's attempt to contain litigation risk this year.Shares in the German agricultural-and-pharmaceutical group were down 5% in European midday trading, taking their year-to-date loss to nearly 10%.Bayer said it plans to oppose a conditional order from the Judicial Panel on Multidistrict Litigation regarding the proper venue for the settlement. The company in February proposed the settlement to resolve current and future claims alleging its Roundup product causes cancer, with payments made over two decades but front-loaded to this year.\"We are confident in our arguments that the class settlement case should be remanded to Missouri State Court,\" a Bayer spokesman said.The move comes two days before a deadline for plaintiffs to opt out of the settlement, which the company considers still valid.The","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BAYRY":"Bayer A.G.","BK4007":"制药"},"translate_title":"拜耳股价因美国70亿美元和解协议再次出现不确定性而下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BAYRY":0.9},"content_text":"By Adria Calatayud \n\n\n \n\n\n  Bayer shares fell after plaintiffs sought to transfer a proposed $7.25 billion U.S. settlement over Roundup weedkiller to a federal court in California, stoking renewed uncertainty around the company's attempt to contain litigation risk this year. \n\n\n  Shares in the German agricultural-and-pharmaceutical group were down 5% in European midday trading, taking their year-to-date loss to nearly 10%. \n\n\n  Bayer said it plans to oppose a conditional order from the Judicial Panel on Multidistrict Litigation regarding the proper venue for the settlement. The company in February proposed the settlement to resolve current and future claims alleging its Roundup product causes cancer, with payments made over two decades but front-loaded to this year. \n\n\n  \"We are confident in our arguments that the class settlement case should be remanded to Missouri State Court,\" a Bayer spokesman said. \n\n\n  The move comes two days before a deadline for plaintiffs to opt out of the settlement, which the company considers still valid. \n\n\n  The decision might raise questions among investors about whether the settlement still holds given the potential involvement of a California federal judge who was cautious on this class action in a recent hearing, analysts at Bank of America wrote in a note to clients. \n\n\n \n\n\n  Write to Adria Calatayud at adria.calatayud@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 02, 2026 07:06 ET (11:06 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2640917344","isCrawlerRequest":true}